Vitamin D receptor rs2228570 polymorphism and susceptibility to ovarian cancer: An updated meta-analysis

被引:14
作者
Chen, Hongmei [1 ]
Zhu, Jin [2 ]
机构
[1] Fudan Univ, Dept Obstet & Gynaecol, Jingan Dist Ctr Hosp Shanghai, Shanghai, Peoples R China
[2] Fudan Univ, Dept Obstet & Gynaecol, Gynecol Hosp, Shanghai, Peoples R China
关键词
FokI; ovarian cancer; polymorphism; rs2228570; vitamin D receptor; GENOME-WIDE ASSOCIATION; GENE POLYMORPHISMS; RISK-FACTORS; FOKI; HETEROGENEITY; BIOLOGY; BREAST; BSMI;
D O I
10.1111/jog.13534
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
AimThe FokI polymorphism (C>T, rs2228570) of the vitamin D receptor gene is a coding nonsynonymous single nucleotide polymorphism in the translational initiation codon reported to have functional significance. Although the role of rs2228570 in the risk of ovarian cancer has been widely researched, the association is still unclear. We performed an updated meta-analysis to clarify this issue. MethodsEligible studies were retrieved from electronic databases for the period 2007-2016. The association was measured by unadjusted odds ratio combined with 95% confidence intervals (CIs). Random-effect or fixed-effect models were used according to the heterogeneity of the studies. We further appreciated the strength of evidence according to Venice guidance. ResultsFourteen studies (4448 cases and 7242 controls) were included in the meta-analysis. Studies were predominantly conducted in Caucasian populations (4152 cases and 6693 controls). A dominant genetic model was determined to be the most appropriate genetic model. Overall meta-analysis showed a fixed-effect odds ratio of 1.14 (95% CI 1.05-1.23) under a dominant model. The fixed-effect odds ratios were 1.12 (95% CI 1.03-1.21) and 1.49 (95% CI 1.06-2.09) in Caucasian and Asian populations, respectively. The strength of the evidence was moderate. ConclusionThe rs2228570 polymorphism increased the risk of ovarian cancer in Caucasian populations in a dominant genetic model. The role of this polymorphism in the risk of ovarian cancer in Asian populations should be further studied.
引用
收藏
页码:556 / 565
页数:10
相关论文
共 42 条
[31]   Mutations in BRIP1 confer high risk of ovarian cancer [J].
Rafnar, Thorunn ;
Gudbjartsson, Daniel F. ;
Sulem, Patrick ;
Jonasdottir, Aslaug ;
Sigurdsson, Asgeir ;
Jonasdottir, Adalbjorg ;
Besenbacher, Soren ;
Lundin, Par ;
Stacey, Simon N. ;
Gudmundsson, Julius ;
Magnusson, Olafur T. ;
le Roux, Louise ;
Orlygsdottir, Gudbjorg ;
Helgadottir, Hafdis T. ;
Johannsdottir, Hrefna ;
Gylfason, Arnaldur ;
Tryggvadottir, Laufey ;
Jonasson, Jon G. ;
de Juan, Ana ;
Ortega, Eugenia ;
Ramon-Cajal, Jose M. ;
Garcia-Prats, Maria D. ;
Mayordomo, Carlos ;
Panadero, Angeles ;
Rivera, Fernando ;
Aben, Katja K. H. ;
van Altena, Anne M. ;
Massuger, Leon F. A. G. ;
Aavikko, Mervi ;
Kujala, Paula M. ;
Staff, Synnove ;
Aaltonen, Lauri A. ;
Olafsdottir, Kristrun ;
Bjornsson, Johannes ;
Kong, Augustine ;
Salvarsdottir, Anna ;
Saemundsson, Hafsteinn ;
Olafsson, Karl ;
Benediktsdottir, Kristrun R. ;
Gulcher, Jeffrey ;
Masson, Gisli ;
Kiemeney, Lambertus A. ;
Mayordomo, Jose I. ;
Thorsteinsdottir, Unnur ;
Stefansson, Kari .
NATURE GENETICS, 2011, 43 (11) :1104-U91
[32]   Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing Therapy [J].
Romero, Ignacio ;
Bast, Robert C., Jr. .
ENDOCRINOLOGY, 2012, 153 (04) :1593-1602
[33]   Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: a meta-analysis [J].
Song, Gwan Gyu ;
Lee, Young Ho .
IMMUNOLOGICAL INVESTIGATIONS, 2013, 42 (07) :661-672
[34]   A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2 [J].
Song, Honglin ;
Ramus, Susan J. ;
Tyrer, Jonathan ;
Bolton, Kelly L. ;
Gentry-Maharaj, Aleksandra ;
Wozniak, Eva ;
Anton-Culver, Hoda ;
Chang-Claude, Jenny ;
Cramer, Daniel W. ;
DiCioccio, Richard ;
Doerk, Thilo ;
Goode, Ellen L. ;
Goodman, Marc T. ;
Schildkraut, Joellen M. ;
Sellers, Thomas ;
Baglietto, Laura ;
Beckmann, Matthias W. ;
Beesley, Jonathan ;
Blaakaer, Jan ;
Carney, Michael E. ;
Chanock, Stephen ;
Chen, Zhihua ;
Cunningham, Julie M. ;
Dicks, Ed ;
Doherty, Jennifer A. ;
Duerst, Matthias ;
Ekici, Arif B. ;
Fenstermacher, David ;
Fridley, Brooke L. ;
Giles, Graham ;
Gore, Martin E. ;
De Vivo, Immaculata ;
Hillemanns, Peter ;
Hogdall, Claus ;
Hogdall, Estrid ;
Iversen, Edwin S. ;
Jacobs, Ian J. ;
Jakubowska, Anna ;
Li, Dong ;
Lissowska, Jolanta ;
Lubinski, Jan ;
Lurie, Galina ;
McGuire, Valerie ;
McLaughlin, John ;
Medrek, Krzysztof ;
Moorman, Patricia G. ;
Moysich, Kirsten ;
Narod, Steven ;
Phelan, Catherine ;
Pye, Carole .
NATURE GENETICS, 2009, 41 (09) :996-U60
[35]   Systematic review and meta-analysis of the association between β2-adrenoceptor polymorphisms and asthma:: A HuGE review [J].
Thakkinstian, A ;
McEvoy, M ;
Minelli, C ;
Gibson, P ;
Hancox, B ;
Duffy, D ;
Thompson, J ;
Hall, I ;
Kaufman, J ;
Leung, TF ;
Helms, PJ ;
Hakonarson, H ;
Halpi, E ;
Navon, R ;
Attia, J .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 162 (03) :201-211
[36]   A method for meta-analysis of molecular association studies [J].
Thakkinstian, A ;
McElduff, P ;
D'Este, C ;
Duffy, D ;
Attia, J .
STATISTICS IN MEDICINE, 2005, 24 (09) :1291-1306
[37]   Polymorphisms in the Vitamin D Receptor and Risk of Ovarian Cancer in Four Studies [J].
Tworoger, Shelley S. ;
Gate, Margaret A. ;
Lee, I-Min ;
Buring, Julie E. ;
Titus-Ernstoff, Linda ;
Cramer, Daniel ;
Hankinson, Susan E. .
CANCER RESEARCH, 2009, 69 (05) :1885-1891
[38]   Genetics and biology of vitamin D receptor polymorphisms [J].
Uitterlinden, AG ;
Fang, Y ;
van Meurs, JBJ ;
Pols, HAP ;
van Leeuwen, JPTM .
GENE, 2004, 338 (02) :143-156
[39]   Crucial Role of Vitamin D in the Musculoskeletal System [J].
Wintermeyer, Elke ;
Ihle, Christoph ;
Ehnert, Sabrina ;
Stoeckle, Ulrich ;
Ochs, Gunnar ;
de Zwart, Peter ;
Flesch, Ingo ;
Bahrs, Christian ;
Nussler, Andreas K. .
NUTRIENTS, 2016, 8 (06)
[40]   The VDR gene FokI polymorphism and ovarian cancer risk [J].
Xu, Hui ;
Li, Su ;
Qiu, Jian-Qing ;
Gao, Xiao-Lin ;
Zhang, Ping ;
Yang, Yong-Xia .
TUMOR BIOLOGY, 2013, 34 (06) :3309-3316